HRT Financial’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

HRT Financial’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,911	Closed	-$381K	–	3345
2024 Q1	$381K	Buy	+17,911	New	+$214K	﹤0.01%	1406
2021 Q3	–	Sell	-14,180	Closed	-$114K	–	3891
2021 Q2	$114K	Buy	+14,180	New	+$122K	﹤0.01%	2565
2020 Q4	–	Sell	-10,068	Closed	-$121K	–	2615
2020 Q3	$121K	Buy	+10,068	New	+$138K	﹤0.01%	1487

HRT Financial's FUSN Position: Q2 2024 in Review

HRT Financial sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 17,911 shares — an estimated $381K sold.

HRT Financial first reported a position in FUSN in Q3 2020 and held it in 3 quarters. The position peaked at $381K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

HRT Financial reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
HRT Financial sold 17,911 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $381K.
HRT Financial first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q3 2020 and held it in 3 quarters.
HRT Financial's Fusion Pharmaceuticals Inc. Common Shares position peaked at $381K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.